Russian Court Compels ViiV Healthcare to License HIV Drug Patent to Promomed

A Russian appellate court ordered ViiV Healthcare to grant a compulsory license to Promomed's Biochemik for an HIV treatment patent, marking a rare forced licensing of a Western pharmaceutical patent. This follows Russia's broader trend of overriding IP protections for essential medicines amid sanctions. The move could set a precedent for other foreign drugmakers and affect market access.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works